AIM ImmunoTech Inc. — Director's Dealing 2011

Feb 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2010-07-16

Reporting Person: Lander Russel J (VP of Process/QualityAssurance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-07-16	Common Stock	P	950	$0.47	Acquired	154023	Direct
2010-07-23	Common Stock	P	1500	$0.52	Acquired	155523	Direct
2010-07-23	Common Stock	P	1000	$0.52	Acquired	156523	Direct
2010-08-23	Common Stock	P	1260	$0.51	Acquired	157783	Direct
2010-08-23	Common Stock	P	200	$0.5	Acquired	157983	Direct